DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 3Dr. Reddy's Laboratories
02 3Pharmathen SA
03 12care4
04 3Acino Pharma (Pty) Ltd
05 6Amdipharm Mercury Company Limited
06 12Amdipharm Mercury Debtco Limited
07 3Biological E
08 1Europharmadk Aps
09 2Farm Agon
10 3Institut Produits Synthèse (IPSEN) AB
11 6InvaGen Pharmaceuticals Inc
12 32Ipsen
13 16Medartuum
14 40ORIFARM GROUP AS
15 1Omnia L?kemedel Ab
16 5Paranova Pharmaceuticals Ab
17 5Pharmachim Ab
18 3Sun Pharmaceutical Industries Limited
19 3Unimedic AB
20 3Zentiva
01 3Injection
02 9Injection fluid, resolution in the finished filled syringe
03 1Lanreotide 120Mg 1 Unit Parenteral Use
04 1Lanreotide 30Mg 1 Unit Parenteral Use Rp
05 1Lanreotide 60Mg 1 Unit Parenteral Use
06 1Lanreotide 90Mg 1 Unit Parenteral Use
07 3Long Acting Injectable
08 3PFS
09 1Powder For Injection
10 3Pre Filled Syringe
11 3SOLUTION (EXTENDED RELEASE)
12 9SOLUTION;SUBCUTANEOUS
13 81Solution For Injection
14 3Solution For Injection For Subcutaneous
15 3Solution For Injection In Pre-Filled
16 2Solution for injection, solution in pre-filled syringe
17 24Blank
01 3Allowed
02 38Approved
03 41Deregistered
04 3EU Approved
05 3Lead Market Dossiers- Under Development
06 3Originator
07 9RX
08 51Blank
01 3IPSTYL
02 9Ipstyl
03 10Ipstyl Autogel
04 6LANREOTIDE ACETATE
05 3Lanreotide Amdipharm
06 3Lanreotide Orifarm
07 3Lanreotide Sun
08 3Lanreotide Zentiva
09 3MYRELEZ
10 2Myrelez
11 12Mytolac
12 3SOMATULINE AUTOGEL
13 1SOMATULINE AUTOGEL 120
14 1SOMATULINE AUTOGEL 60
15 1SOMATULINE AUTOGEL 90
16 3SOMATULINE DEPOT
17 13Somatulina Autogel
18 62Somatuline Autogel
19 1Somatuline Pr
20 9Blank
01 24Australia
02 3Canada
03 3Greece
04 6India
05 10Italy
06 11Norway
07 3South Africa
08 79Sweden
09 3Switzerland
10 9USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 60MG/0.2ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Long Acting Injectable
Dosage Strength : 60MG/SYRINGE
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 90MG/0.3ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 120MG/0.5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Long Acting Injectable
Dosage Strength : 90MG/SYRINGE
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Long Acting Injectable
Dosage Strength : 120MG/SYRINGE
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Regulatory Info : RX
Registration Country : USA
Brand Name : LANREOTIDE ACETATE
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : EQ 60MG BASE/0.2ML (EQ 60MG BASE/0.2ML)
Packaging :
Approval Date : 2021-12-17
Application Number : 215395
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LANREOTIDE ACETATE
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : EQ 90MG BASE/0.3ML (EQ 90MG BASE/0.3ML)
Packaging :
Approval Date : 2021-12-17
Application Number : 215395
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LANREOTIDE ACETATE
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : EQ 120MG BASE/0.5ML (EQ 120MG BASE/0.5ML)
Packaging :
Approval Date : 2021-12-17
Application Number : 215395
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LANREOTIDE ACETATE
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : EQ 60MG BASE/0.2ML (EQ 60MG BASE/0.2ML)
Packaging :
Approval Date : 2024-05-21
Application Number : 217193
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LANREOTIDE ACETATE
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : EQ 90MG BASE/0.3ML (EQ 90MG BASE/0.3ML)
Packaging :
Approval Date : 2024-05-21
Application Number : 217193
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LANREOTIDE ACETATE
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : EQ 120MG BASE/0.5ML (EQ 120MG BASE/0.5ML)
Packaging :
Approval Date : 2024-05-21
Application Number : 217193
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SOMATULINE DEPOT
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : EQ 60MG BASE/0.2ML (EQ 60MG BASE/0.2ML)
Packaging :
Approval Date : 2007-08-30
Application Number : 22074
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SOMATULINE DEPOT
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : EQ 90MG BASE/0.3ML (EQ 90MG BASE/0.3ML)
Packaging :
Approval Date : 2007-08-30
Application Number : 22074
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SOMATULINE DEPOT
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : EQ 120MG BASE/0.5ML (EQ 120MG BASE/0.5ML)
Packaging :
Approval Date : 2007-08-30
Application Number : 22074
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Brand Name : Ipstyl
Dosage Form : Lanreotide 120Mg 1 Unit Parenteral Use
Dosage Strength : 1 syringe SC 120 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Ipstyl
Dosage Form : Lanreotide 30Mg 1 Unit Parenteral Use Rp
Dosage Strength : 1 bottle IM 30 mg prolonged release + 1 Vial 2 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Ipstyl
Dosage Form : Lanreotide 60Mg 1 Unit Parenteral Use
Dosage Strength : 1 syringe SC 60 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Ipstyl
Dosage Form : Lanreotide 90Mg 1 Unit Parenteral Use
Dosage Strength : 1 syringe SC 90 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Norway
Brand Name : Ipstyl
Dosage Form : Injection fluid, resolution in the finished filled syringe
Dosage Strength : 120 mg
Packaging : Finish filled syringe
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
